NDC 21695-367

EPIVIR

Lamivudine

EPIVIR is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Rebel Distributors Corp. The primary component is Lamivudine.

Product ID21695-367_166abd26-675e-4832-9d18-0567f2a9d4e4
NDC21695-367
Product TypeHuman Prescription Drug
Proprietary NameEPIVIR
Generic NameLamivudine
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date1995-11-21
Marketing CategoryNDA / NDA
Application NumberNDA020564
Labeler NameRebel Distributors Corp
Substance NameLAMIVUDINE
Active Ingredient Strength150 mg/1
Pharm ClassesHepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA]
NDC Exclude FlagE
Listing Certified Through2017-12-31

Packaging

NDC 21695-367-06

6 TABLET, FILM COATED in 1 BOTTLE (21695-367-06)
Marketing Start Date1995-11-21
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 21695-367-06 [21695036706]

EPIVIR TABLET, FILM COATED
Marketing CategoryNDA
Application NumberNDA020564
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1995-11-21
Inactivation Date2019-09-24

Drug Details

Active Ingredients

IngredientStrength
LAMIVUDINE150 mg/1

OpenFDA Data

SPL SET ID:166abd26-675e-4832-9d18-0567f2a9d4e4
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 199147
  • 152931
  • Pharmacological Class

    • Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
    • Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
    • Nucleoside Analog [EXT]
    • Nucleoside Reverse Transcriptase Inhibitors [MoA]

    NDC Crossover Matching brand name "EPIVIR" or generic name "Lamivudine"

    NDCBrand NameGeneric Name
    0173-0662EPIVIRlamivudine
    0173-0663EPIVIRlamivudine
    21695-367EPIVIRlamivudine
    49702-203EPIVIRlamivudine
    49702-204EPIVIRlamivudine
    49702-205EPIVIRlamivudine
    50090-0550EPIVIRlamivudine
    53808-0245EPIVIREPIVIR
    53808-0246EPIVIREPIVIR
    0904-6583LAMIVUDINElamivudine
    10135-605LamivudineLamivudine
    31722-001lamivudinelamivudine
    31722-752LamivudineLamivudine
    31722-753LamivudineLamivudine
    31722-754LamivudineLamivudine
    33342-001LamivudineLamivudine
    33342-002LamivudineLamivudine

    Trademark Results [EPIVIR]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    EPIVIR
    EPIVIR
    78906783 3227835 Live/Registered
    VIIV HEALTHCARE COMPANY
    2006-06-13
    EPIVIR
    EPIVIR
    74213040 1981308 Live/Registered
    VIIV HEALTHCARE COMPANY
    1991-10-11

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.